| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/28/1999 | US5958426 Sphingolipids and a process thereto |
| 09/28/1999 | US5958412 Administering conjugate of antibody and anti-cancer drug, where in antibody is specific for a33 antigen for promoting colon or gastric cancer regression |
| 09/28/1999 | US5958405 Human protein tyrosine kinase |
| 09/28/1999 | US5958401 Method of using IL-11 for treating psoriasis |
| 09/28/1999 | US5958400 Isolated polypeptide comprising specified amino acid sequence |
| 09/28/1999 | CA2076678C Improved chimeric toxins |
| 09/28/1999 | CA1340773C Anti-neoplastic, anti-viral or anti-retoviral sperime derivative |
| 09/23/1999 | WO1999047929A1 Development of human monoclonal antibodies and uses thereof |
| 09/23/1999 | WO1999047708A1 Antisense modulation of pecam-1 |
| 09/23/1999 | WO1999047707A1 Antisense modulation of lfa-3 |
| 09/23/1999 | WO1999047703A1 Method for producing agents for treating tumour diseases and for immunosuppression |
| 09/23/1999 | WO1999047690A2 Multigene vectors |
| 09/23/1999 | WO1999047687A1 Enhanced anti-tumor immunity |
| 09/23/1999 | WO1999047678A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 09/23/1999 | WO1999047675A1 Mu-1, member of the cytokine receptor family |
| 09/23/1999 | WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | WO1999047673A2 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | WO1999047672A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | WO1999047669A2 Human nucleic acid sequences from tissue of breast tumors |
| 09/23/1999 | WO1999047668A2 Nucleic acid which codes for tumor suppressor proteins, tumor suppressor proteins, a method for the production thereof, an antibody against tumor suppressor proteins, and the use of these substances |
| 09/23/1999 | WO1999047655A2 Human nucleic acid fragments with heightened expression in normal breast tissue |
| 09/23/1999 | WO1999047653A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/23/1999 | WO1999047563A2 Ribonucleotide polypeptides containing metal |
| 09/23/1999 | WO1999047554A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 09/23/1999 | WO1999047550A1 Novel matrix metalloproteinase inhibitors and down-regulators |
| 09/23/1999 | WO1999047545A2 Inhibitors of caspases |
| 09/23/1999 | WO1999047538A1 Cytokine receptor common gamma chain like |
| 09/23/1999 | WO1999047534A1 Compounds having immunomodulatory effects |
| 09/23/1999 | WO1999047533A1 Compounds having immunomodulatory effects |
| 09/23/1999 | WO1999047529A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 09/23/1999 | WO1999047522A1 Granulatimide derivatives for use in cancer treatment |
| 09/23/1999 | WO1999047521A1 HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS |
| 09/23/1999 | WO1999047518A1 Substituted bisindolymaleimides for the inhibition of cell proliferation |
| 09/23/1999 | WO1999047512A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 09/23/1999 | WO1999047502A1 Cytotoxic metal chelators and methods for making and using same |
| 09/23/1999 | WO1999047179A1 COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN DELIVERY TO ANTIGEN PRESENTING CELLS $i(IN VIVO) |
| 09/23/1999 | WO1999047178A1 Novel complementing receptor-ligand pairs and adoptive immunotherapy using same |
| 09/23/1999 | WO1999047169A1 Methods to provoke anti-cancer immune responses |
| 09/23/1999 | WO1999047162A1 Products in the treatment of cancer |
| 09/23/1999 | WO1999047158A2 Therapeutic chemokine receptor antagonists |
| 09/23/1999 | WO1999047152A2 Use of dipeptidyl peptidase (dpp4) of fibroblast activating protein alpha for suppressing the malignant phenotype of cancer cells |
| 09/23/1999 | WO1999047143A1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 09/23/1999 | WO1999046992A1 Induction of immunity against tumor self-antigens |
| 09/23/1999 | WO1999041374A3 Human short-chain tnf-receptor family protein |
| 09/23/1999 | WO1999041369A3 Genetic vaccine vector engineering |
| 09/23/1999 | WO1999040944A3 Hydroxylation activated drug release |
| 09/23/1999 | WO1999039740A8 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 09/23/1999 | WO1999039694A3 Compositions containing organic compounds |
| 09/23/1999 | WO1999033859A9 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 09/23/1999 | WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 09/23/1999 | WO1999012531A3 Hormonal contraceptive |
| 09/23/1999 | DE19813839A1 Human nucleic acid sequences and protein products from tumor breast tissue, useful for breast cancer therapy |
| 09/23/1999 | DE19813835A1 Human nucleic acid sequences and protein products from normal breast tissue, useful for breast cancer therapy |
| 09/23/1999 | CA2625284A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 09/23/1999 | CA2324337A1 Products in the treatment of cancer |
| 09/23/1999 | CA2324270A1 Hypnotic .beta.-carboline derivatives, process for their preparation and their use as medicinal products |
| 09/23/1999 | CA2324138A1 Novel complementing receptor-ligand pairs and adoptive immunotherapy using same |
| 09/23/1999 | CA2323897A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/23/1999 | CA2323637A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | CA2323604A1 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 09/23/1999 | CA2323112A1 Multigene vectors |
| 09/23/1999 | CA2323095A1 Metal-containing ribonucleotide polypeptides |
| 09/23/1999 | CA2323093A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | CA2323083A1 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/23/1999 | CA2322699A1 Compositions and methods for enhanced antigen delivery to antigen presenting cells in vivo |
| 09/23/1999 | CA2322660A1 Enhanced anti-tumor immunity |
| 09/23/1999 | CA2319493A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943684A2 Frizzled-like polypeptides and polynucleotides |
| 09/22/1999 | EP0943680A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/22/1999 | EP0943615A1 1,4-dihydropyridine derivatives |
| 09/22/1999 | EP0943333A1 Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis |
| 09/22/1999 | EP0943331A2 Formulations containing oxaliplatin |
| 09/22/1999 | EP0943328A2 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 09/22/1999 | EP0942995A1 Novel calpaines, production and use thereof |
| 09/22/1999 | EP0942980A1 Tumor-associated kazal inhibitor with pec-60 homology |
| 09/22/1999 | EP0942977A2 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942931A2 Modulation of interactions between myosin and integrins |
| 09/22/1999 | EP0942925A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 09/22/1999 | EP0942920A1 Steroid esters, method for the manufacture thereof and their pharmaceutical use |
| 09/22/1999 | EP0942916A2 Nucleosides |
| 09/22/1999 | EP0942915A1 Pharmaceutical formulations |
| 09/22/1999 | EP0942906A2 Compounds useful for inhibition of farnesyl protein transferase |
| 09/22/1999 | EP0942896A1 Substituted phenols and thiophenols useful as antioxidant agents |
| 09/22/1999 | EP0942780A1 Coated particles, methods of making and using |
| 09/22/1999 | EP0942757A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof |
| 09/22/1999 | EP0942754A2 Conjugates useful in the treatment of prostate cancer |
| 09/22/1999 | EP0813531B1 Antitumour isocoumarins |
| 09/22/1999 | EP0663900B1 Metal-oxime chelates for use as radiopharmaceutical agents |
| 09/22/1999 | EP0620741B1 Cytotoxic drug therapy |
| 09/22/1999 | CN1229436A Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 09/22/1999 | CN1229414A Multivalent compounds for cross-linking receptors and uses thereof |
| 09/22/1999 | CN1229412A Inhibitors of interleukin-1'beta' converting emzyme |
| 09/22/1999 | CN1229407A Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 09/22/1999 | CN1229359A Dendritic cell stimulatory factor |
| 09/22/1999 | CN1045207C Farnesyl: protein transfer-enzyme inhibitors as anticancer agents |
| 09/22/1999 | CN1045204C 10,11-methanodibenzosuberane derivatives, preparation method and composition |
| 09/22/1999 | CN1045162C Method for preparing pharmaceutical products for curing tumourous |